Navigation Links
Michigan Life Sciences Pipeline to Kick Off MichBio Expo
Date:8/27/2007

ANN ARBOR, Mich., Aug. 27 /PRNewswire/ -- The Michigan Life Sciences Pipeline announced today two new concurrent events that will lead into the opening reception of the 2007 MichBio Expo. The Michigan Life Sciences Pipeline is a legislative initiative to promote the development and commercialization of the life sciences in the state. It is being developed by MichBio, the state's life sciences trade association.

The Pipeline events are scheduled from 1-5 pm at the Lansing Center, Lansing, Michigan on October 16, 2007 and include:

Governor's Roundtable on Commercialization and Innovation in the Life Sciences. This high-level program will focus on larger policy issues affecting the commercialization of Michigan's life sciences industry. In a moderated discussion, a blue-ribbon panel of industry, entrepreneurial, investment, business, and technology experts will discuss a variety of relevant topics including research incentives, technology transfer, capital formation, industry infrastructure, business climate (tax and legal policies) and education/workforce development. An interactive Q&A and dialogue period will follow.

Manufacturers Forum. This session will focus on how traditional manufacturers can break into the medical device arena. The panel will consist of individuals who have made the transition and one or two representatives from a large medical device company, a small medical device company, and a contract manufacturer. They will outline various business strategies and discuss how manufacturing companies can gain entry into this important sector of the life sciences. This will be an informative event for any manufacturer considering diversification into the medical device arena. Sponsors include the Michigan Manufacturing Technology Center, the Society of Manufacturing Engineers, the Michigan Manufacturers Association, and the Jackson Area Manufacturers Association.

Go to http://www.michbio.org/Expo for more details and registration information.

"The MichBio Expo provides us the perfect venue to introduce the Pipeline to our key constituents, Michigan's small-and mid-size life science companies," said Pipeline program director, Steve Field. "By pairing these events with the MichBio Expo Opening Reception, participants will be able to gain valuable information and then have an opportunity to walk the exhibit floor to network with the life science community."

The Pipeline is intended to focus resources on building commercial life sciences activity in the state. Once complete, the Pipeline will help move companies along the development continuum more rapidly by providing access to training and education, funding resources, networking and partnering opportunities, talent and facilities, legal assistance, etc. An interactive Pipeline website will go live later this year.

Partnering with MichBio in the development of the Pipeline are: CJPS Enterprises, a Bloomfield Hills firm headed by Christophe Sevrain, providing entrepreneurial leadership for companies, as well as Biosciences Research Commercialization Center in Kalamazoo, Biotechnology Business Consultants in Ann Arbor, the Core Technology Alliance (CTA), the state's SmartZones, and the Automotive Resources Institute.


'/>"/>
SOURCE The Michigan Life Sciences Pipeline
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Venture Investors to open Michigan office
2. University of Michigan plans major stem cell research center
3. CPM contributes marketing program to Michigan hospital
4. For Now, Michigan Can Celebrate $150 Million Entrepreneurial VC Fund
5. Michigan Growth Capital Symposium includes Wisconsin Tech Companies
6. Automation of the Eppendorf Perfectprep BAC 96 DNA Kit on the Caliper Life Sciences Sciclone ALH 3000
7. Perscitus Biosciences secures $250K Commerce loan
8. Wisconsin biosciences rise to the challenge
9. Wisconsin professors elected to National Academy of Sciences
10. Quintessence Biosciences advances cancer drug
11. Quintessence Biosciences names new president
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... Cumberland Foreside, Maine (PRWEB) , ... January 17, ... ... to announce the addition of Rheumatoid Factor (RF) to its VALIDATE® SP2 calibration ... and Rheumatoid Factor in a human serum base. Each VALIDATE® SP2 kit is ...
(Date:1/17/2017)... DIEGO , Jan. 17, 2017  An ... School of Medicine and St. Boniface Hospital Albrechtsen ... for peripheral neuropathy, an unmet health need affecting ... the Journal of Clinical Investigation, their results identify ... that prevent and reverse neuronal injury in animal ...
(Date:1/17/2017)... 2017   Pulmatrix, Inc . (NASDAQ: ... inhaled therapies to address serious pulmonary diseases, today announced ... the lungs of CF patients, PUR1900, has been designated ... U.S. Food & Drug Administration. Under ... the development of novel drugs against important pathogens, Pulmatrix ...
(Date:1/17/2017)...  Only nine percent of U.S. consumers believe pharmaceutical ... 16 percent believe health insurance companies do, according to ... of U.S. adults believe health care providers (such as ... hospitals (23%). "We are in the midst ... , vice president of reputation management and public affairs ...
Breaking Biology Technology:
(Date:12/15/2016)... , Dec. 14, 2016 "Increase in mobile ... market" The mobile biometrics market is expected to grow ... billion by 2022, at a CAGR of 29.3% between ... such as the growing demand for smart devices, government ... "Software component is expected to grow at ...
(Date:12/7/2016)... , December 7, 2016 According to a new market ... Software Tool (Facial Expression, Voice Recognition), Service, Application Area, End User, And Region ... to grow from USD 6.72 Billion in 2016 to USD 36.07 Billion by ... Continue Reading ... MarketsandMarkets ...
(Date:12/6/2016)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) (the "Company") ... million principal amount of its 1.414% senior unsecured notes due ... unsecured notes due 2026. The closing of ... to the satisfaction of customary closing conditions.  The notes will ... The Company intends to use the net proceeds from ...
Breaking Biology News(10 mins):